These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2575177

  • 1. Metabolic changes during antihypertensive therapies.
    Krone W, Nägele H.
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [Abstract] [Full Text] [Related]

  • 2. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H.
    J Cardiovasc Pharmacol; 1987 Dec; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Dec; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 4. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J, Chanu B, Bakir R, Sauvanet JP.
    J Pharmacol; 1983 Dec; 14 Suppl 2():183-99. PubMed ID: 6138467
    [Abstract] [Full Text] [Related]

  • 5. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL, Lenz ML, Taylor AA.
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [Abstract] [Full Text] [Related]

  • 6. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Oct; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 7. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P, de Courten M, Ferrari P, Böhlen L.
    J Cardiovasc Pharmacol; 1993 Oct; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [Abstract] [Full Text] [Related]

  • 8. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P.
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
    [Abstract] [Full Text] [Related]

  • 9. Terazosin: a new antihypertensive agent with favorable effects on lipids.
    Luther RR.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
    [Abstract] [Full Text] [Related]

  • 10. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
    Sauvanet JP, Rouffy J.
    Pathol Biol (Paris); 1981 Sep; 29(7):435-40. PubMed ID: 6117048
    [Abstract] [Full Text] [Related]

  • 11. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK, Neuman SL.
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [Abstract] [Full Text] [Related]

  • 12. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982 Jun; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 13. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 14. Altered adrenergic control in hypercholesterolemia.
    Ohanian J, Nicolosi RJ, Vatner SF, Graham RM, Kowala MC, Young MA.
    J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 9():S11-5. PubMed ID: 2447434
    [Abstract] [Full Text] [Related]

  • 15. Regulation of lipoprotein metabolism by adrenergic mechanisms.
    Dzau VJ, Sacks FM.
    J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 9():S2-6. PubMed ID: 2447436
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of antihypertensives on blood lipids.
    Ballantyne D.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():35-7. PubMed ID: 1973462
    [Abstract] [Full Text] [Related]

  • 17. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS, Hirokawa WT.
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [Abstract] [Full Text] [Related]

  • 18. [Antihypertensive therapy and lipid metabolism].
    Krone W, Müller-Wieland D, Greten H.
    Klin Wochenschr; 1984 Mar 01; 62(5):193-202. PubMed ID: 6143851
    [Abstract] [Full Text] [Related]

  • 19. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM.
    Circulation; 1990 Sep 01; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [Abstract] [Full Text] [Related]

  • 20. Effects of antihypertensives on plasma lipids and lipoprotein metabolism.
    Krone W, Nägele H.
    Am Heart J; 1988 Dec 01; 116(6 Pt 2):1729-34. PubMed ID: 3059788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.